DL-Pyroglutamic acid

DL-Pyroglutamic acid

• CAS Number: 149-87-1
• UNSPSC Description: DL-Pyroglutamic acid (CAE) as an inactivator of hepatitis B surface, inactivates vaccinia virus, herpes simplex virus, and influenza virus except poliovirus. DL-Pyroglutamic acid is also a possible inhibitor of GABA transaminase, increases GABA amount with antiepileptic action[1][2].
• Target Antigen: GABA Receptor; Influenza Virus
• Type: Reference compound
• Related Pathways: Anti-infection;Membrane Transporter/Ion Channel;Neuronal Signaling
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/dl-pyroglutamic-acid.html
• Purity: 98.0
• Solubility: DMSO : 100 mg/mL (ultrasonic)
• Smiles: O=C(C1NC(CC1)=O)O
• Molecular Weight: 129.11
• References & Citations: [1]Sugimoto Y, et al. N-alpha-Cocoyl-L-arginine ethyl ester, DL-pyroglutamic acid salt, as an inactivator of hepatitis B surface antigen. Antimicrob Agents Chemother. 1979 Sep;16(3):329-32.
• Shipping Conditions: Room Temperature
• Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
• Clinical Information: No Development Reported